---
title: "EAST-ASIA PHARMACEUTICAL released its performance for the first three quarters, with a net loss attributable to the parent company of 72.41 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263548546.md"
description: "According to the Zhitong Finance APP, EAST-ASIA PHARMACEUTICAL disclosed its third-quarter report for 2025. The company achieved a revenue of 596 million yuan in the first three quarters, a year-on-year decrease of 38.08%; the net profit attributable to shareholders was a loss of 72.41 million yuan; the net profit excluding non-recurring items was a loss of 81.98 million yuan; the basic earnings per share were -0.63 yuan"
datetime: "2025-10-30T14:22:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263548546.md)
  - [en](https://longbridge.com/en/news/263548546.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263548546.md)
---

# EAST-ASIA PHARMACEUTICAL released its performance for the first three quarters, with a net loss attributable to the parent company of 72.41 million yuan

According to the Zhitong Finance APP, EAST-ASIA PHARMACEUTICAL (605177.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 596 million yuan in the first three quarters, a year-on-year decrease of 38.08%; the net profit attributable to shareholders was a loss of 72.41 million yuan; the net profit excluding non-recurring gains and losses was a loss of 81.98 million yuan; basic earnings per share were -0.63 yuan

### Related Stocks

- [605177.CN](https://longbridge.com/en/quote/605177.CN.md)

## Related News & Research

- [Should You Be Adding Daewoong Pharmaceutical (KRX:069620) To Your Watchlist Today?](https://longbridge.com/en/news/286824214.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [While Everyone Chases AI, Pharma Keeps Getting Cheaper](https://longbridge.com/en/news/286650835.md)
- [Rare nickels that could fund your dreams](https://longbridge.com/en/news/286856785.md)
- [Claritas Rx Strengthens Executive Team with New CRO and Two VP Promotions](https://longbridge.com/en/news/286794376.md)